Using rTMS to Treat Depression in Veterans with Spinal Cord Injuries
Official title: Evaluating a Novel Method to Determine the rTMS Dose Needed for Treating Depression After Spinal Cord Injury
Run by VA Office of Research and Development · NCT05553353 · Data updated 2026-11-12
This study is testing a new way to use brain stimulation to help veterans with spinal cord injuries who are struggling with depression.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Charleston, South Carolina) |
| Status | Recruiting |
| Started | March 31, 2025 |
| Main results expected | April 15, 2027 |
| Study ends | October 29, 2027 |
| Registry record updated | January 14, 2026 |
| Trial ID | NCT05553353 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are veterans with cervical or thoracic spinal cord injuries who have been diagnosed with major depressive disorder.
✕Probably not a fit
Patients with concomitant neurological disorders, cognitive impairments, or those currently on antidepressant medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the use of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depressive disorder in individuals who have experienced spinal cord injuries (SCI). The study aims to develop a novel dosing technique for rTMS that does not rely on motor responses, which is crucial since many SCI patients have upper extremity impairments. By focusing on this specific population, the trial seeks to improve treatment accessibility and effectiveness for those suffering from depression post-SCI. The study will assess the antidepressant effects of rTMS in eligible participants over a defined period.
Why it matters
Potential benefit: If successful, this study could provide an effective treatment option for depression in veterans with spinal cord injuries, improving their quality of life and recovery outcomes.
How similar studies have gone: While rTMS has been shown to be effective for depression in general populations, this specific application for veterans with spinal cord injuries is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * cervical or thoracic spinal cord injury at least 6 months prior with AIS A, B, C, or D; * 18 - 60 years of age; * major depressive disorder, as identified by Structured Clinical Interview for DSM-V; * Hamilton Depression Rating Scale-17 score \> 18; * not taking antidepressant medications or no change in doses of psychotropic medication(s) for at least 4 weeks before the study (6 weeks if newly initiated medication) Exclusion Criteria: * concomitant neurologic diseases/disorders or dementia; * cognitive impairment (Montreal Cognitive Assessment \<17); * history of psychosis or other Axis I disorder that is primary; * positive screen for bipolar disorder through the Mini-International Neuropsychiatric Interview; * history of claustrophobia; * life expectancy \<1 year; * electronic or metallic implants (i.e., metal in the head, cochlear implant, or pacemaker; * history of seizures or currently prescribed anti-seizure medications; * taking medication that increases the risk of seizures; * pregnancy as identified through a positive urine pregnancy test; * Hamilton Depression Rating Scale-17 question #3 regarding suicide: \>2 or suicide attempt within the previous two years; * inability to (University of California, San Diego Brief Assessment of Capacity to Consent) or declined to give informed consent.
Where it's running
-
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, United States Recruiting
Study contacts
- Principal investigator: Catherine J VanDerwerker, PhD DPT PT — Ralph H. Johnson VA Medical Center, Charleston, SC
- Study coordinator: Catherine J VanDerwerker, PhD DPT PT
- Email: catherine.vanderwerker@va.gov
- Phone: (843) 792-5047
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing two methods of brain stimulation for treating depression in adolescents
This study is testing if a faster way of brain stimulation can help teenagers with hard-to-treat depression feel better compared to the standard method.
-
Testing a new drug for treatment-resistant depression
This study is testing a new drug called HNK to see if it can help people with treatment-resistant depression feel better when other medications haven't worked.
-
Comparing two methods of brain stimulation for treating depression
This study is testing if a personalized brain stimulation method can help people with major depressive disorder feel better compared to the standard treatment.
-
Treatment for depression in individuals with spinal cord injuries
This study is testing if a new treatment called rTMS can help people with spinal cord injuries who are also dealing with depression feel better.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury
This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.